Dapagliflozin

A sodium-glucose cotransporter 2 (sglt2) inhibitor that helps your kidneys remove excess sugar from your blood into your urine.

Linagliptin

A dipeptidyl peptidase-4 (dpp-4) inhibitor that helps your body release more insulin when needed and reduces the amount of sugar your liver produces.

Metformin

A biguanide that helps your body use insulin more effectively and reduces the amount of sugar your liver produces.

Treatment of type 2 diabetes mellitus in adults inadequately controlled with metformin alone or in combination with other oral antihyperglycemic agents.

May be used as part of a comprehensive diabetes management plan that includes diet, exercise, and weight management.

This triple combination medication works through three distinct mechanisms to lower blood sugar levels. Dapagliflozin increases glucose excretion in the urine, linagliptin enhances insulin secretion and reduces glucagon secretion, and metformin improves insulin sensitivity and reduces hepatic glucose production.

Store at room temperature (59-86°F or 15-30°C). Protect from moisture and light. Keep out of reach of children.

Dosage should be determined by your doctor based on your individual needs and response to treatment.

The medication is typically taken orally with a meal to reduce gastrointestinal side effects.

Do not crush, chew, or break the tablets.

Hypoglycemia (low blood sugar)

Urinary tract infections

Yeast infections (candidiasis)

Nausea

Vomiting

Diarrhea

Constipation

Headache

Fatigue

Weight loss

Dehydration

Ketoacidosis (rare, but serious)

Alcohol Consumption

Alcohol may increase the risk of hypoglycemia. Limit alcohol consumption.



While Driving or operating Machinery

If you experience hypoglycemia or dizziness, avoid driving or operating machinery.



Pregnant & Breastfeeding Women

This medication is generally not recommended during pregnancy or breastfeeding. Consult your doctor.



Children

Not recommended for children.



Kidney

Renal function should be assessed before starting and regularly monitored during treatment. Dosage adjustment may be needed in patients with kidney disease.



Liver

Liver function should be assessed before starting treatment. Use with caution in patients with liver disease.

Consult your doctor or pharmacist for more detailed information and references to relevant medical literature.